[1]
A. F. L. Waitzberg, A. F. do V. Franco, J. T. de Araujo Neto, and F. S. Pasini, “Immunoexpression of markers related to the human epidermal growth factor receptor-type 2 (HER2) pathway in cases of pure positive HER2 breast carcinoma treated with trastuzumab”, MAST, vol. 35, no. suppl.1, Feb. 2026.